Spin-Off of Theravance Biopharma, Inc. (Tables)

9 Months Ended

Sep. 30, 2014

Spin-Off of Theravance Biopharma, Inc.

Schedule of net book value of assets that were contributed in connection with the Spin-Off

	June 2,
(In thousands)	2014
Cash and cash equivalents	$	277,541
Marketable investment securities	115,129
Accounts receivable	125
Reimbursement of certain liabilities	16,983
Prepaid and other current assets	3,172
Inventories	14,328
Fixed assets, net	9,580
Accrued liabilities	(22,342		)
Deferred revenue	(6,694		)
Other liabilities	(4,944		)
Net book value of assets contributed	$	402,878